Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rx-To-OTC Switch Flips On With June Public Forum, July NDAC Meeting

This article was originally published in The Tan Sheet

Executive Summary

The suitability of specific Rx drug classes - such as antihypertensive agents, osteoporosis treatments and oral contraceptives - for OTC use will be examined by FDA at a June 28-29 meeting in Gaithersburg, Md.

You may also be interested in...



OTC Cholesterol Drugs Preferred Over Supplements, NCL Survey Finds

Consumers would use OTC cholesterol-lowering drugs instead of dietary supplements currently marketed as maintaining healthy cholesterol levels, a survey conducted by the National Consumers League finds.

OTC Cholesterol Drugs Preferred Over Supplements, NCL Survey Finds

Consumers would use OTC cholesterol-lowering drugs instead of dietary supplements currently marketed as maintaining healthy cholesterol levels, a survey conducted by the National Consumers League finds.

OTC Cholesterol Drugs Preferred Over Supplements, NCL Survey Finds

Consumers would use OTC cholesterol-lowering drugs instead of dietary supplements currently marketed as maintaining healthy cholesterol levels, a survey conducted by the National Consumers League finds.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091164

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel